4ixv
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | ==Crystal structure of human Arginase-2 complexed with inhibitor 2d: {(5R)-5-amino-5-carboxy-5-[1-(4-chlorobenzyl)piperidin-4-yl]pentyl}(trihydroxy)borate(1-)== | |
- | + | <StructureSection load='4ixv' size='340' side='right' caption='[[4ixv]], [[Resolution|resolution]] 2.30Å' scene=''> | |
- | { | + | == Structural highlights == |
+ | <table><tr><td colspan='2'>[[4ixv]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4IXV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4IXV FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BEN:BENZAMIDINE'>BEN</scene>, <scene name='pdbligand=BME:BETA-MERCAPTOETHANOL'>BME</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene>, <scene name='pdbligand=XA1:{(5R)-5-AMINO-5-CARBOXY-5-[1-(4-CHLOROBENZYL)PIPERIDIN-4-YL]PENTYL}(TRIHYDROXY)BORATE(1-)'>XA1</scene></td></tr> | ||
+ | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1d3v|1d3v]], [[1pq3|1pq3]], [[4ixu|4ixu]]</td></tr> | ||
+ | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ARG2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
+ | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Arginase Arginase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.3.1 3.5.3.1] </span></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ixv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ixv OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ixv RCSB], [http://www.ebi.ac.uk/pdbsum/4ixv PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The Ugi reaction has been successfully applied to the synthesis of novel arginase inhibitors. In an effort to decrease conformational flexibility of the previously reported series of 2-amino-6-boronohexanoic acid (ABH) analogs 1, we designed and synthesized a series of compounds, 2, in which a piperidine ring is linked directly to a quaternary amino acid center. Further improvement of in vitro activity was achieved by adding two carbon bridge in the piperidine ring, that is, tropane analogs 11. These improvements in activity are rationalized by X-ray crystallography analysis, which show that the tropane ring nitrogen atom moves into direct contact with Asp202 (arginase II numbering). The synthetic routes described here enabled the design of novel arginase inhibitors with improved potency and markedly different physico-chemical properties compared to ABH. Compound 11c represents the most in vitro active arginase inhibitor reported to date. | ||
- | + | Synthesis of quaternary alpha-amino acid-based arginase inhibitors via the Ugi reaction.,Golebiowski A, Whitehouse D, Beckett RP, Van Zandt M, Ji MK, Ryder TR, Jagdmann E, Andreoli M, Lee Y, Sheeler R, Conway B, Olczak J, Mazur M, Czestkowski W, Piotrowska W, Cousido-Siah A, Ruiz FX, Mitschler A, Podjarny A, Schroeter H Bioorg Med Chem Lett. 2013 Sep 1;23(17):4837-41. doi: 10.1016/j.bmcl.2013.06.092., Epub 2013 Jul 8. PMID:23886684<ref>PMID:23886684</ref> | |
- | + | ||
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | + | </div> | |
- | + | == References == | |
- | == | + | <references/> |
- | + | __TOC__ | |
+ | </StructureSection> | ||
[[Category: Arginase]] | [[Category: Arginase]] | ||
- | [[Category: Andreoli, M | + | [[Category: Human]] |
- | [[Category: Beckett, P | + | [[Category: Andreoli, M]] |
- | [[Category: Cousido-Siah, A | + | [[Category: Beckett, P]] |
- | [[Category: Czestkowski, W | + | [[Category: Cousido-Siah, A]] |
- | [[Category: Golebiowski, A | + | [[Category: Czestkowski, W]] |
- | [[Category: Jagdmann, R | + | [[Category: Golebiowski, A]] |
- | [[Category: Ji, M K | + | [[Category: Jagdmann, R]] |
- | [[Category: Mazur, M | + | [[Category: Ji, M K]] |
- | [[Category: Mitschler, A | + | [[Category: Mazur, M]] |
- | [[Category: Olczak, J | + | [[Category: Mitschler, A]] |
- | [[Category: Piotrowska, W | + | [[Category: Olczak, J]] |
- | [[Category: Podjarny, A | + | [[Category: Piotrowska, W]] |
- | [[Category: Ruiz, F X | + | [[Category: Podjarny, A]] |
- | [[Category: Ryder, T | + | [[Category: Ruiz, F X]] |
- | [[Category: Schroeter, H | + | [[Category: Ryder, T]] |
- | [[Category: Whitehouse, D | + | [[Category: Schroeter, H]] |
- | [[Category: Zandt, M C.Van | + | [[Category: Whitehouse, D]] |
+ | [[Category: Zandt, M C.Van]] | ||
[[Category: Alpha/beta fold]] | [[Category: Alpha/beta fold]] | ||
[[Category: Arginine metabolism]] | [[Category: Arginine metabolism]] |
Revision as of 16:24, 21 December 2014
Crystal structure of human Arginase-2 complexed with inhibitor 2d: {(5R)-5-amino-5-carboxy-5-[1-(4-chlorobenzyl)piperidin-4-yl]pentyl}(trihydroxy)borate(1-)
|
Categories: Arginase | Human | Andreoli, M | Beckett, P | Cousido-Siah, A | Czestkowski, W | Golebiowski, A | Jagdmann, R | Ji, M K | Mazur, M | Mitschler, A | Olczak, J | Piotrowska, W | Podjarny, A | Ruiz, F X | Ryder, T | Schroeter, H | Whitehouse, D | Zandt, M C.Van | Alpha/beta fold | Arginine metabolism | Hydrolase | Hydrolase-hydrolase inhibitor complex | Metalloenzyme | Mitochondrion